Juvenile	B:C0263666
dermatomyositis	I:C0263666
with	O
anti-signal	O
recognition	O
particle	O
antibodies	O
:	O
a	O
case	O
report	I:C0085973
.	O

Juvenile	O
dermatomyositis	I:C0263666
with	O
anti-signal	O
recognition	O
particle	O
antibodies	O
:	O
a	O
case	B:C0085973
report	I:C0085973
.	O

Serologic	O
investigation	B:C0220825
has	O
been	O
explored	O
in	O
inflammatory	O
myopathies	I:C0027121
in	O
order	O
to	O
define	O
subgroups	O
that	O
can	O
help	O
us	O
predict	O
clinical	O
course	O
,	O
treatment	O
and	O
prognosis	O
.	O

Serologic	O
investigation	O
has	O
been	O
explored	O
in	O
inflammatory	B:C0027121
myopathies	I:C0027121
in	O
order	O
to	O
define	O
subgroups	O
that	O
can	O
help	O
us	O
predict	O
clinical	O
course	O
,	O
treatment	O
and	O
prognosis	O
.	O

Serologic	O
investigation	O
has	O
been	O
explored	O
in	O
inflammatory	O
myopathies	I:C0027121
in	O
order	O
to	O
define	O
subgroups	B:C1515021
that	O
can	O
help	O
us	O
predict	O
clinical	O
course	O
,	O
treatment	O
and	O
prognosis	O
.	O

Serologic	O
investigation	O
has	O
been	O
explored	O
in	O
inflammatory	O
myopathies	I:C0027121
in	O
order	O
to	O
define	O
subgroups	O
that	O
can	O
help	O
us	O
predict	O
clinical	O
course	O
,	O
treatment	B:C0087111
and	O
prognosis	O
.	O

Serologic	O
investigation	O
has	O
been	O
explored	O
in	O
inflammatory	O
myopathies	I:C0027121
in	O
order	O
to	O
define	O
subgroups	O
that	O
can	O
help	O
us	O
predict	O
clinical	O
course	O
,	O
treatment	O
and	O
prognosis	B:C0033325
.	O

The	O
level	O
of	O
similarity	O
between	O
juvenile	B:C2895180
and	O
adult	O
myopathies	O
regarding	O
the	O
presence	O
of	O
myositis	O
-	O
specific	O
autoantibodies	O
has	O
not	O
been	O
fully	O
elucidated	O
.	O

The	O
level	O
of	O
similarity	O
between	O
juvenile	O
and	O
adult	O
myopathies	B:C0026848
regarding	O
the	O
presence	O
of	O
myositis	O
-	O
specific	O
autoantibodies	O
has	O
not	O
been	O
fully	O
elucidated	O
.	O

The	O
level	O
of	O
similarity	O
between	O
juvenile	O
and	O
adult	O
myopathies	O
regarding	O
the	O
presence	B:C0150312
of	O
myositis	O
-	O
specific	O
autoantibodies	O
has	O
not	O
been	O
fully	O
elucidated	O
.	O

The	O
level	O
of	O
similarity	O
between	O
juvenile	O
and	O
adult	O
myopathies	O
regarding	O
the	O
presence	O
of	O
myositis	B:C0027121
-	O
specific	O
autoantibodies	O
has	O
not	O
been	O
fully	O
elucidated	O
.	O

The	O
level	O
of	O
similarity	O
between	O
juvenile	O
and	O
adult	O
myopathies	O
regarding	O
the	O
presence	O
of	O
myositis	O
-	O
specific	O
autoantibodies	B:C0004358
has	O
not	O
been	O
fully	O
elucidated	O
.	O

We	O
report	O
the	O
case	O
of	O
a	O
8	O
-	O
year	O
-	O
old	O
girl	O
who	O
presented	O
with	O
a	O
rapid	B:C1838681
progression	I:C1838681
of	O
muscle	O
weakness	I:C0151786
and	O
cutaneous	O
signs	O
consistent	O
with	O
the	O
diagnosis	O
of	O
juvenile	O
dermatomyositis	I:C0263666
and	O
whose	O
serologic	O
testing	O
revealed	O
the	O
presence	O
of	O
anti-signal	O
recognition	O
particle	O
(	O
SRP	O
)	O
antibodies	O
.	O

We	O
report	O
the	O
case	O
of	O
a	O
8	O
-	O
year	O
-	O
old	O
girl	O
who	O
presented	O
with	O
a	O
rapid	O
progression	I:C1838681
of	O
muscle	B:C0151786
weakness	I:C0151786
and	O
cutaneous	O
signs	O
consistent	O
with	O
the	O
diagnosis	O
of	O
juvenile	O
dermatomyositis	I:C0263666
and	O
whose	O
serologic	O
testing	O
revealed	O
the	O
presence	O
of	O
anti-signal	O
recognition	O
particle	O
(	O
SRP	O
)	O
antibodies	O
.	O

We	O
report	O
the	O
case	O
of	O
a	O
8	O
-	O
year	O
-	O
old	O
girl	O
who	O
presented	O
with	O
a	O
rapid	O
progression	I:C1838681
of	O
muscle	O
weakness	I:C0151786
and	O
cutaneous	B:C0221912
signs	O
consistent	O
with	O
the	O
diagnosis	O
of	O
juvenile	O
dermatomyositis	I:C0263666
and	O
whose	O
serologic	O
testing	O
revealed	O
the	O
presence	O
of	O
anti-signal	O
recognition	O
particle	O
(	O
SRP	O
)	O
antibodies	O
.	O

We	O
report	O
the	O
case	O
of	O
a	O
8	O
-	O
year	O
-	O
old	O
girl	O
who	O
presented	O
with	O
a	O
rapid	O
progression	I:C1838681
of	O
muscle	O
weakness	I:C0151786
and	O
cutaneous	O
signs	B:C0037088
consistent	O
with	O
the	O
diagnosis	O
of	O
juvenile	O
dermatomyositis	I:C0263666
and	O
whose	O
serologic	O
testing	O
revealed	O
the	O
presence	O
of	O
anti-signal	O
recognition	O
particle	O
(	O
SRP	O
)	O
antibodies	O
.	O

We	O
report	O
the	O
case	O
of	O
a	O
8	O
-	O
year	O
-	O
old	O
girl	O
who	O
presented	O
with	O
a	O
rapid	O
progression	I:C1838681
of	O
muscle	O
weakness	I:C0151786
and	O
cutaneous	O
signs	O
consistent	O
with	O
the	O
diagnosis	B:C0011900
of	O
juvenile	O
dermatomyositis	I:C0263666
and	O
whose	O
serologic	O
testing	O
revealed	O
the	O
presence	O
of	O
anti-signal	O
recognition	O
particle	O
(	O
SRP	O
)	O
antibodies	O
.	O

We	O
report	O
the	O
case	O
of	O
a	O
8	O
-	O
year	O
-	O
old	O
girl	O
who	O
presented	O
with	O
a	O
rapid	O
progression	I:C1838681
of	O
muscle	O
weakness	I:C0151786
and	O
cutaneous	O
signs	O
consistent	O
with	O
the	O
diagnosis	O
of	O
juvenile	B:C0263666
dermatomyositis	I:C0263666
and	O
whose	O
serologic	O
testing	O
revealed	O
the	O
presence	O
of	O
anti-signal	O
recognition	O
particle	O
(	O
SRP	O
)	O
antibodies	O
.	O

We	O
report	O
the	O
case	O
of	O
a	O
8	O
-	O
year	O
-	O
old	O
girl	O
who	O
presented	O
with	O
a	O
rapid	O
progression	I:C1838681
of	O
muscle	O
weakness	I:C0151786
and	O
cutaneous	O
signs	O
consistent	O
with	O
the	O
diagnosis	O
of	O
juvenile	O
dermatomyositis	I:C0263666
and	O
whose	O
serologic	O
testing	O
revealed	O
the	O
presence	B:C0150312
of	O
anti-signal	O
recognition	O
particle	O
(	O
SRP	O
)	O
antibodies	O
.	O

So	O
far	O
these	O
antibodies	B:C0003241
have	O
been	O
described	O
mostly	O
in	O
adult	O
subsets	O
,	O
frequently	O
associated	O
with	O
poorer	O
outcomes	O
and	O
rarely	O
related	O
to	O
cutaneous	O
manifestations	O
.	O

So	O
far	O
these	O
antibodies	O
have	O
been	O
described	O
mostly	O
in	O
adult	O
subsets	B:C1515021
,	O
frequently	O
associated	O
with	O
poorer	O
outcomes	O
and	O
rarely	O
related	O
to	O
cutaneous	O
manifestations	O
.	O

So	O
far	O
these	O
antibodies	O
have	O
been	O
described	O
mostly	O
in	O
adult	O
subsets	O
,	O
frequently	O
associated	O
with	O
poorer	O
outcomes	O
and	O
rarely	O
related	O
to	O
cutaneous	B:C0221912
manifestations	O
.	O

The	O
knowledge	O
of	O
the	O
degree	O
of	O
overlap	O
between	O
paediatric	B:C0030755
and	O
adult	O
anti-signal	O
recognition	I:C0074512
particle	I:C0074512
positive	O
myopathies	O
may	O
improve	O
the	O
medical	O
care	I:C0496675
we	O
provide	O
to	O
these	O
children	O
.	O

The	O
knowledge	O
of	O
the	O
degree	O
of	O
overlap	O
between	O
paediatric	O
and	O
adult	O
anti-signal	B:C0074512
recognition	I:C0074512
particle	I:C0074512
positive	O
myopathies	O
may	O
improve	O
the	O
medical	O
care	I:C0496675
we	O
provide	O
to	O
these	O
children	O
.	O

The	O
knowledge	O
of	O
the	O
degree	O
of	O
overlap	O
between	O
paediatric	O
and	O
adult	O
anti-signal	O
recognition	I:C0074512
particle	I:C0074512
positive	B:C1446409
myopathies	O
may	O
improve	O
the	O
medical	O
care	I:C0496675
we	O
provide	O
to	O
these	O
children	O
.	O

The	O
knowledge	O
of	O
the	O
degree	O
of	O
overlap	O
between	O
paediatric	O
and	O
adult	O
anti-signal	O
recognition	I:C0074512
particle	I:C0074512
positive	O
myopathies	B:C0026848
may	O
improve	O
the	O
medical	O
care	I:C0496675
we	O
provide	O
to	O
these	O
children	O
.	O

The	O
knowledge	O
of	O
the	O
degree	O
of	O
overlap	O
between	O
paediatric	O
and	O
adult	O
anti-signal	O
recognition	I:C0074512
particle	I:C0074512
positive	O
myopathies	O
may	O
improve	O
the	O
medical	B:C0496675
care	I:C0496675
we	O
provide	O
to	O
these	O
children	O
.	O

